RECRUITINGOBSERVATIONAL
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Longitudinal Protocol for Eosinophilic Granulomatosis With Polyangiitis
About This Trial
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of this disease in people with EGPA.
Who May Be Eligible (Plain English)
Who May Qualify:
Patients with a diagnosis of eosinophilic granulomatosis with polyangiitis are eligible for the study.
Parent or guardian willing to provide willing to sign a consent form, if applicable
Who Should NOT Join This Trial:
\- Inability to give willing to sign a consent form and to sign the consent form
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
Patients with a diagnosis of eosinophilic granulomatosis with polyangiitis are eligible for the study.
Parent or guardian willing to provide informed consent, if applicable
Exclusion Criteria:
\- Inability to give informed consent and to sign the consent form
Locations (13)
University of California San Diego
San Diego, California, United States
National Jewish Health
Denver, Colorado, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Mayo Clinic
Rochester, Minnesota, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
University of Utah
Salt Lake City, Utah, United States
St. Joseph's Healthcare
Hamilton, Ontario, Canada
Mount Sinai Hospital
Toronto, Ontario, Canada
medius KLINIK KIRCHHEIM
Kirchheim unter Teck, Germany
AOU Meyer IRCCS
Florence, Italy
Imperial College Healthcare NHS Trust/ Imperial College London
London, United Kingdom